Posters
Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)
March 3, 2026
More infoPosters
Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity
March 3, 2026
More infoPosters
Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry
March 3, 2026
More infoPosters
Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?
November 10, 2025
Proteomics/Mass Spectrometry
More infoPosters
Artificial Intelligence-powered Spatial Analysis of Tumor Microenvironment Identifies Immune Phenotype in Non- Small Cell Lung Cancer, Colorectal Cancer and Urothelial Cancer.
October 30, 2025
More infoPosters
Combining high-plex proteomics with single-cell transcriptomics for deep characterization of antigen-specific T cell responses
October 30, 2025
More infoPosters
High Quality Whole Transcriptome RNA-Sequencing from Challenging Clinical Samples
June 23, 2025
More infoPosters
Performance Evaluation of an Ultra-Sensitive Assay for NSCLC Biomarker Testing
June 23, 2025
More info